Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SNYNF crawled date : 2022 - 12 - 08 save search
Alnylam Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration (FDA) for ONPATTRO® (patisiran) for the Treatment of the Cardiomyopathy of ATTR Amyloidosis
Published: 2022-12-08 (Crawled : 22:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
ALNY | $146.07 0.19% 0.18% 0
|
Health Technology
|
| O: 0.43%
H: 3.16%
C: 2.44%
onpattro treatment drug application food
COALITION TO STOP FLU APPLAUDS INTRODUCTION OF LEGISLATION TO BETTER PROTECT AMERICA FROM SEASONAL AND PANDEMIC INFLUENZA
Published: 2022-12-08 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
america influenza
Sanofi Backs Out of Revolution Partnership in Latest Cancer Cull
Published: 2022-12-08 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
RVMD | $36.125 -0.37% 35K
|
Health Technology
|
| O: 1.41%
H: 1.22%
C: 1.06%
partnership cancer sanofi
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
Published: 2022-12-08 (Crawled : 16:00) - globenewswire.com
FNCTF | News | $11.16 1.13% 0
|
Communications
|
| O: -0.76%
H: 0.0%
C: 0.0%
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
PFE | News 4 | $26.085 -0.89% 2.7M
|
Health Technology
|
| O: -0.12%
H: 3.36%
C: 3.19%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
BNTX | News | $88.37 -0.14% 27K
|
Health Technology
|
| O: 0.37%
H: 5.31%
C: 5.26%
covid-19 fda children vaccine authorization
Wren Taps Vertex Veteran Executives and Other Leaders to Advance First-in-Class Small-Molecule Drugs into Clinical Testing for Neurodegenerative Diseases
Published: 2022-12-08 (Crawled : 15:20) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
neurodegenerative
LISCure's Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA
Published: 2022-12-08 (Crawled : 14:20) - prnewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
fda designation drug candidate granted phase 2
CANCER RESEARCH INSTITUTE VIRTUAL IMMUNOTHERAPY PATIENT SUMMIT IS NOW AVAILABLE FREE, ON-DEMAND
Published: 2022-12-08 (Crawled : 12:20) - prnewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
LLY | News | $741.05 -0.62% 220K
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: -0.39%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
REGN | News | $912.99 0.63% 34K
|
Health Technology
|
| O: -0.81%
H: 2.76%
C: 0.97%
research immunotherapy cancer
Lung cancer therapeutics market size to grow by USD 10,204.33 million: High prevalence of lung cancer remains key growth driver - Technavio
Published: 2022-12-08 (Crawled : 08:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% 0
|
Health Technology
|
| O: 1.92%
H: 0.0%
C: 0.0%
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
AZNCF | News | $140.3 1.13% 0
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: 0.0%
NVSEF | News | $96.0 0.94% 0
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
ALPMY | News | $9.49 -0.42% 55K
|
Manufacturing
|
| O: 1.24%
H: 0.97%
C: 0.19%
NVS | News | $97.86 0.6% 420K
|
Health Technology
|
| O: -1.17%
H: 1.09%
C: 1.01%
GSK | News | $41.03 -0.51% 89K
|
Health Technology
|
| O: -1.41%
H: 1.75%
C: 0.66%
ABBV | News | $168.48 -0.63% 110K
|
Health Technology
|
| O: 0.0%
H: 0.5%
C: 0.36%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
AZN | News | $71.19 0.48% 1M
|
Health Technology
|
| O: 0.13%
H: 0.76%
C: 0.33%
AMGN | News | $270.69 -1.04% 120K
|
Health Technology
|
| O: 0.26%
H: 0.03%
C: -0.33%
lung therapeutics cancer growth market
Endocrinology drugs market size to grow by USD 36551.24 Million: Increase in the incidence of endocrine disorders remains key growth driver - Technavio
Published: 2022-12-07 (Crawled : 00:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K
|
n/a
|
| O: 0.0%
H: 11.11%
C: 2.78%
GLAXF | News | $19.54 -3.77% 0
|
Health Technology
|
| O: 1.92%
H: 0.0%
C: 0.0%
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
NVSEF | News | $96.0 0.94% 0
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVS | News | $97.86 0.6% 420K
|
Health Technology
|
| O: -1.17%
H: 1.09%
C: 1.01%
GSK | News | $41.03 -0.51% 89K
|
Health Technology
|
| O: -1.41%
H: 1.75%
C: 0.66%
ABT | News | $106.84 -0.7% 5.5K
|
Health Technology
|
| O: -0.14%
H: 2.32%
C: 2.16%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
ORMP A | $2.35 0.86% 2.51% 0
|
Health Technology
|
| O: 0.48%
H: 4.55%
C: 3.47%
endocrine growth market endocrine disorders
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
CZOO | $9.98 100.0% 330K
|
AMST | $3.48 74.0% 21M
|
Technology Services
BOF | $1.78 52.14% 15M
|
SYRA | $1.5 51.23% 1M
|
n/a
CSSE 4 | $0.2184 43.4% 36M
|
Consumer Services
RILY | $30.325 39.62% 6.8M
|
Finance
TROO | $1.41 29.36% 280K
|
Manufacturing
MULN | News | $3.445 26.19% 980K
|
Information
RBBN 4 | $3.21 24.9% 580K
|
Electronic Technology
LICN | $0.6987 24.77% 4.4M
|
Your saved searches
Save your searches and get alerts when important news are released.